Actavis PLC is acquiring Allergan Inc. in a transaction valued at about $66 billion. The combination will create one of the top-10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015.
The Food and Drug Administration is reclassifying methylphenidate hydrochloride extended-release tablets from Kremers Urban Pharmaceuticals Inc. as the agency seeks more bioequivalence information.
Conglomerate Berkshire Hathaway Inc. has agreed to acquire the Duracell battery business from Procter & Gamble Co. The companies said Thursday that the deal, encompassing roughly $6.
Information and imaging technology giant Xerox is making an investment in telehealth provider HealthSpot Inc.
Kirby Lester reported a spike in sales of its KL1 and KL1Plus tablet counters in October following the Drug Enforcement Agency’s reclassification of hydrocodone combination products to Schedule II. Kirby Lester KL1 (left) and KL1Plus tablet counters.
Aaron Loutsch has been promoted to senior vice president and chief technology officer (CTO).
Eli Lilly and Co. has released Trulicity, a once-weekly treatment for type 2 diabetes, to U.S. pharmacies. Lilly said Monday that Trulicity (dulaglutide) comes in a single-dose pen, in 0.75 mg and 1.5 mg doses, and doesn’t require patients to mix, measure, or handle the needle.
Jolen Inc. has rolled out a new look for its Jolen Creme Bleach hair formula. The company said Monday that Jolen Creme Bleach retains its iconic logo and package color but sports a new package design to freshen up the brand’s look.
Mylan Inc., maker of the EpiPen epinephrine auto-injectors, has signed a multiyear agreement with Walt Disney Parks and Resorts to help raise awareness of anaphylaxis, a life-threatening allergic reaction.
J.P. Bilbrey Hershey said Friday that the newly created private-sector advisory council will focus on bolstering U.S. commercial relationships with African nations. "It is a great honor to be selected and to serve on this advisory council to our president," Bilbrey said in a statement.
PepsiCo Inc. president Zein Abdalla plans to step down from his post at the end of this year. Zein Abdalla In an 8-K filing with the Securities and Exchange Commission on Thursday, PepsiCo said Abdalla notified the company that he has decided to retire effective Dec. 31.
Perrigo Co. plc has reinitiated shipments of guaifenesin 600-mg extended-release tablets to its U.S. retail and wholesale customers.
Hershey Co. has launched Reese’s Spreads, a combination of chocolate and peanut butter flavors in spreadable form. Hershey said Wednesday that Reese’s Spreads, based on the Reese’s Peanut Butter Cup, will appeal to consumers because it can be "enjoyed on any food, anytime, anywhere.
Mylan Inc. has released norethindrone acetate and ethinyl estradiol tablets (1 mg/0.02 mg) and ferrous fumarate, a birth control pill, in the United States. Mylan said Wednesday that the oral contraceptive product is a generic version of Loestrin 24 Fe from Warner Chilcott.
Snack maker Snyder’s-Lance Inc. plans to form a new, "better for you" division. Snyder’s-Lance said the move supports its goal of creating a stronger presence in a healthier, more sustainable food industry.
The Food and Drug Administration has approved updated prescribing information for Sanofi Pasteur’s Fluzone High-Dose influenza vaccine for seniors.
